NCT03656523

Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 598 (actual)
• Sponsor: Heart Care Foundation · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

ACS are a potent risk factor for AF, with new onset AF occurring in up to 1 in every 5 patients hospitalized with an ACS. Despite its relatively frequent occurrence and the many etiologic factors involved in its pathogenetic condition, the frequency and prognostic significance of AF complicating ACS remain unclear

Detailed description

There are limited data available, particularly from a representative population-based perspective describing recent pharmacological and non-pharmacological management and clinical event rates associated with AF complicating ACS in the era of novel treatment strategies (in both AF and ACS) and high coronary reperfusion rates. This registry will assess the current in-hospital management and clinical events at 6 months of consecutive patients admitted in Italian cardiology intensive care units (CCUs) for an ACS treated invasively with PCI and stent implantation who present AF at admission or during hospital stay, before or after stent implantation .

Conditions

• Acute Coronary Syndrome
• Atrial Fibrillation

Interventions

Type	Name	Description
OTHER	Acute coronary syndrome and PCI and AF	Patient with ACS and ACS treated with PCI

Timeline

• Start date: 2018-07-25
• Primary completion: 2020-08-17
• Completion: 2020-08-17
• First posted: 2018-09-04
• Last updated: 2021-02-03

Locations

76 sites across 1 country: Italy